FAQ
Ozempic cost questions
How much does Ozempic cost with insurance?
Most commercially insured patients with a type 2 diabetes diagnosis pay $25–$200/month for Ozempic. Tier 2 plans average $25–$45/month; Tier 3 plans $95–$200/month after deductible. Coverage requires a diabetes diagnosis on most plans.
Does insurance cover Ozempic for weight loss?
No — Ozempic is FDA-approved only for type 2 diabetes. Insurance plans typically require a diabetes diagnosis to cover Ozempic. For weight loss, Wegovy (same active ingredient) is the FDA-approved option and may be covered if your plan includes weight-loss benefits.
Is there a generic for Ozempic?
No. Ozempic (semaglutide) is brand-only with no generic available. Patent expirations begin in 2031. Compounded semaglutide is not FDA-approved and not equivalent.
What is the Ozempic savings card?
The Novo Nordisk Ozempic Savings Card caps eligible commercially insured patients at $25/month with a maximum of $150 in savings per 28-day supply. Medicare, Medicaid, and uninsured patients are not eligible but may qualify for Novo Nordisk patient assistance programs.
What insurance tier is Ozempic on?
Ozempic is typically Tier 2 on most commercial plans with a diabetes diagnosis. Some plans place it on Tier 3, especially newer or smaller employer plans. Prior authorization is sometimes required to confirm the diabetes diagnosis.
How does Ozempic compare to Trulicity?
Both Ozempic (semaglutide) and Trulicity (dulaglutide) are GLP-1 agonists for type 2 diabetes dosed weekly. Ozempic has shown larger A1C reductions in head-to-head trials. Coverage varies by plan; some plans prefer one over the other based on rebate agreements.
What if my insurance denies Ozempic?
Options: (1) confirm your prescriber documented a type 2 diabetes diagnosis, (2) appeal with A1C documentation, (3) switch to a covered GLP-1 alternative (Trulicity, Mounjaro, Rybelsus), or (4) use the Novo Nordisk Patient Assistance Program if you meet financial criteria.
Does Medicare Part D cover Ozempic?
Yes, Medicare Part D plans typically cover Ozempic for type 2 diabetes, often at Tier 2 or 3. Under the Inflation Reduction Act, insulin costs are capped at $35/month for Medicare patients, and similar caps may extend to other diabetes drugs in future plan years.